Investment Rating - The report maintains a "Buy" rating for SenseTime-W (0020.HK) and raises the target price to HKD 2.72 [1][10]. Core Insights - SenseTime reported a revenue of RMB 5.015 billion for 2025, marking a historical high with a year-on-year growth of 33%. The generative AI business surged by 51% to RMB 3.6 billion, accounting for 72% of total revenue, indicating significant progress in the strategic shift towards generative AI [2][10]. - The company achieved a notable improvement in profitability, with net losses narrowing by 58.6% and EBITDA losses reducing by 85% to RMB 470 million. The second half of 2025 saw the company achieve its first positive EBITDA of RMB 380 million and positive operating cash flow, marking a critical transition from a technology investment phase to a commercial harvesting phase [10]. - The NEO architecture is leading multi-modal integration, establishing a competitive edge that is difficult to replicate. The Q4 2025 release of the Neo native multi-modal architecture achieved state-of-the-art performance using only 10% of the data and computing power compared to industry standards [10]. - The company's three-in-one strategy is transitioning AI applications from technical validation to large-scale commercial realization, with significant breakthroughs in generative AI applications. The "Little Raccoon" family has served over 15 million users, and the Vimi platform supports the continuous generation of short dramas [10]. Financial Summary - For 2025, the company forecasts revenues of RMB 6.506 billion in 2026, RMB 8.107 billion in 2027, and RMB 9.867 billion in 2028, with growth rates of 30%, 25%, and 22% respectively [5][12]. - The net profit attributable to the parent company is projected to improve from a loss of RMB 1.766 billion in 2025 to a profit of RMB 172 million by 2028, reflecting a significant turnaround [5][12]. - The report highlights a projected EBITDA of RMB 1.568 billion by 2028, indicating a strong recovery in operational performance [12].
商汤-W（00020）：2025年报点评：多模态融合筑壁垒，经营造血夯根基